Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease.
Crohn’s disease
bladder
malignant
neoplasm
ulcerative colitis
ureter
urethra
urinary
urothelium
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 Jul 2021
23 Jul 2021
Historique:
received:
03
07
2021
revised:
22
07
2021
accepted:
22
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
8
8
2021
Statut:
epublish
Résumé
Extraintestinal cancers are important complications in patients with inflammatory bowel disease (IBD). A limited number of publications are available regarding the association between IBD and urothelial cancer. The primary outcome of our study was the comparison of the prevalence of urothelial cancer in patients with IBD with respect to the prevalence in the general population. Secondary outcomes were the assessment of risk factors for the onset of urothelial cancer in IBD. In a retrospective study we examined the medical records of all patients with a confirmed diagnosis of IBD followed in our clinic between 1978 and 2021. For each of the patients with identified urothelial cancer, more than ten patients without cancer were analyzed. Furthermore, 5739 patients with IBD were analyzed and 24 patients diagnosed with urothelial cancer were identified. The incidence of urothelial cancer, compared with the incidence in the general population, was not significantly different (0.42% vs. 0.42%;
Identifiants
pubmed: 34362041
pii: jcm10153257
doi: 10.3390/jcm10153257
pmc: PMC8347965
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Gastroenterol. 2010 Jul;105(7):1480-7
pubmed: 20332773
J Crohns Colitis. 2017 Aug 1;11(8):954-962
pubmed: 28333358
Clin Gastroenterol Hepatol. 2014 Feb;12(2):265-73.e1
pubmed: 23602821
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Transl Androl Urol. 2021 Jan;10(1):164-173
pubmed: 33532306
Clin Gastroenterol Hepatol. 2010 Mar;8(3):268-74
pubmed: 20005977
Prz Gastroenterol. 2014;9(3):153-9
pubmed: 25097712
Inflamm Bowel Dis. 2018 Feb 15;24(3):617-623
pubmed: 29390104
Aliment Pharmacol Ther. 2016 Jan;43(2):252-61
pubmed: 26549003
Scand J Urol Nephrol Suppl. 2008 Sep;(218):64-78
pubmed: 18815919
Am J Gastroenterol. 2013 Dec;108(12):1869-76
pubmed: 23978954
Inflamm Bowel Dis. 2020 Feb 11;26(3):450-459
pubmed: 31498388
Scand J Gastroenterol. 2013 Dec;48(12):1405-13
pubmed: 24131389
Medicina (Kaunas). 2020 Jun 11;56(6):
pubmed: 32545154
Ann Oncol. 2009 Mar;20(3):574-80
pubmed: 18765463
Cancer Prev Res (Phila). 2016 Dec;9(12):887-894
pubmed: 27679553
Scand J Urol Nephrol Suppl. 2008 Sep;(218):45-54
pubmed: 18815916
Cancer. 2001 Feb 15;91(4):854-62
pubmed: 11241255
N Engl J Med. 2015 Apr 9;372(15):1441-52
pubmed: 25853748
Front Immunol. 2018 Jan 30;9:74
pubmed: 29441064
Cancer. 1991 Apr 1;67(7):2015-9
pubmed: 2004319
J Crohns Colitis. 2019 Feb 1;13(2):144-164
pubmed: 30137275
Adv Exp Med Biol. 2014;816:183-96
pubmed: 24818724
Int J Cancer. 2008 Sep 15;123(6):1417-21
pubmed: 18561319
Med Health R I. 2009 Mar;92(3):73-7
pubmed: 19385381
Gastroenterology. 1994 Dec;107(6):1675-9
pubmed: 7958678
Int J Cancer. 2016 Sep 15;139(6):1270-80
pubmed: 27170593
Digestion. 2016;94(1):1-8
pubmed: 27318857
J Clin Med. 2019 Nov 14;8(11):
pubmed: 31739460
Eur Urol. 2018 Dec;74(6):784-795
pubmed: 30268659
World J Gastroenterol. 2013 Dec 28;19(48):9359-65
pubmed: 24409063
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1324-9
pubmed: 24582568